Archelos JJ - Search Results

1

Cerebrospinal fluid lipocalin 2 in patients with clinically isolated syndromes and early multiple sclerosis.

Khalil M, Renner A, Langkammer C, Enzinger C, Ropele S, Stojakovic T, Scharnagl H, Bachmaier G, Pichler A, Archelos JJ, Fuchs S, Seifert-Held T, Fazekas F. Khalil M, et al. Among authors: archelos jj. Mult Scler. 2016 Oct;22(12):1560-1568. doi: 10.1177/1352458515624560. Epub 2016 Jan 13. Mult Scler. 2016. PMID: 26762671

2

Chlamydia pneumoniae in multiple sclerosis: humoral immune responses in serum and cerebrospinal fluid and correlation with disease activity marker.

Krametter D, Niederwieser G, Berghold A, Birnbaum G, Strasser-Fuchs S, Hartung HP, Archelos JJ. Krametter D, et al. Among authors: archelos jj. Mult Scler. 2001 Feb;7(1):13-8. doi: 10.1177/135245850100700103. Mult Scler. 2001. PMID: 11321187

3

IVIG therapy in neurological disorders of childhood.

Archelos JJ, Fazekas F. Archelos JJ, et al. J Neurol. 2006 Sep;253 Suppl 5:V80-6. doi: 10.1007/s00415-006-5014-y. J Neurol. 2006. PMID: 16998760 Review.

4

Statins as immunomodulators: comparison with interferon-beta 1b in MS.

Neuhaus O, Strasser-Fuchs S, Fazekas F, Kieseier BC, Niederwieser G, Hartung HP, Archelos JJ. Neuhaus O, et al. Among authors: archelos jj. Neurology. 2002 Oct 8;59(7):990-7. doi: 10.1212/wnl.59.7.990. Neurology. 2002. PMID: 12370451

5

Laboratory diagnosis of Lyme neuroborreliosis is influenced by the test used: comparison of two ELISAs, immunoblot and CXCL13 testing.

Wutte N, Archelos J, Crowe BA, Zenz W, Daghofer E, Fazekas F, Aberer E. Wutte N, et al. J Neurol Sci. 2014 Dec 15;347(1-2):96-103. doi: 10.1016/j.jns.2014.09.027. Epub 2014 Sep 26. J Neurol Sci. 2014. PMID: 25288328

6

Tau protein and 14-3-3 are elevated in the cerebrospinal fluid of patients with multiple sclerosis and correlate with intrathecal synthesis of IgG.

Bartosik-Psujek H, Archelos JJ. Bartosik-Psujek H, et al. Among authors: archelos jj. J Neurol. 2004 Apr;251(4):414-20. doi: 10.1007/s00415-004-0336-0. J Neurol. 2004. PMID: 15083285

7

Prevalence of autoimmune thyroiditis and non-immune thyroid disease in multiple sclerosis.

Niederwieser G, Buchinger W, Bonelli RM, Berghold A, Reisecker F, Költringer P, Archelos JJ. Niederwieser G, et al. Among authors: archelos jj. J Neurol. 2003 Jun;250(6):672-5. doi: 10.1007/s00415-003-1053-9. J Neurol. 2003. PMID: 12796827

8

The role of B cells and autoantibodies in multiple sclerosis.

Archelos JJ, Storch MK, Hartung HP. Archelos JJ, et al. Ann Neurol. 2000 Jun;47(6):694-706. Ann Neurol. 2000. PMID: 10852535 Review.

9

Statins in multiple sclerosis: a new therapeutic option?

Neuhaus O, Archelos JJ, Hartung HP. Neuhaus O, et al. Among authors: archelos jj. Mult Scler. 2003 Oct;9(5):429-30. doi: 10.1191/1352458503ms952ed. Mult Scler. 2003. PMID: 14582764 Review. No abstract available.

10

The immunopathogenesis of multiple sclerosis. A survey of recent advances and implications for future therapy.

Kieseier BC, Archelos JJ, Storch M, Gold R, Hartung HP. Kieseier BC, et al. Among authors: archelos jj. Wien Klin Wochenschr. 1999 Sep 17;111(17):728-37. Wien Klin Wochenschr. 1999. PMID: 10526397 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

59 results

Search Page

Filters